The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Sharma is a consultant to Novartis, Allergan, Bayer, Lupin, and Intas and has received a speaker fee from Biogen. Dr. Loewenstein is a consultant to Allergan, Novartis, Roche, Notal Vision, Fiorsightslabs, Beyeonics, and Bayer Health Care. Dr. Kuppermann performs clinical research for Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, and ThromboGenics and is a consultant to Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, and Theravance Biopharma. Drs. Parachuri and Kumar declared no conflicts of interest.